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Background: The efﬁcacy of thrombectomy during percutaneous coronary intervention (PCI)
for ST-segment elevation acute myocardial infarction (STEMI) has not yet been fully evaluated.
The aim of this retrospective study was to evaluate the usefulness of manual thrombectomy for
STEMI and to clarify whether different infarct-related arteries (IRAs) inﬂuence the efﬁcacy of
thrombectomy.
Methods and results: We enrolled 183 patients with STEMI who underwent PCI within 24 h after
onset between October 2001 and January 2004. We divided these patients into 2 groups, namely
88 patients who had undergone PCI after manual thrombectomy (Th+ group) and 95 patients
who were treated with PCI alone (Th− group). The Th+ group had lower incidences of dis-
tal embolization and no-reﬂow phenomenon than the Th− group (6.8% vs. 27.4%, p = 0.0003;
and 5.7% vs. 23.2%, p = 0.0009, respectively). The percentage of complete ST-segment resolu-
tion (STR) after PCI and left ventricular ejection fraction 6 months after the procedure were
signiﬁcantly higher in the Th+ group (43.2% vs. 20%, p = 0.002; and 60.1% vs. 54.8%, p = 0.004,
respectively). Regarding different IRAs, the percentage of complete STR was signiﬁcantly higher
in patients with proximal left anterior descending coronary artery (LAD) and right coronary
artery (RCA) lesions in the Th+ group (37.5% vs. 9.7%, p < 0.05; and 59.5% vs. 30.3%, p < 0.05,
respectively). Incidences of adverse events were similar in both groups.
Conclusions: Manual thrombectomy for STEMI can improve myocardial reperfusion after PCI
and left ventricular function late after the procedure. With respect to different IRAs, manual
thrombectomy for STEMI is more effective in proximal LAD and RCA lesions.
© 2009 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.
∗ Corresponding author. Tel.: +81 436 88 3111; fax: +81 436 88 3032.
E-mail address: kigen.seo.jo@nifty.ne.jp (K. Jo).










































































































ercutaneous coronary intervention (PCI) has been reported
o be effective for ST-segment elevation acute myocardial
nfarction (STEMI) [1]. However, distal embolization and/or
o-reﬂow phenomenon during PCI can result in unfavorable
utcomes after PCI [2—5]. It has been reported that dis-
al embolization can occur in as many as 15.2% of acute
yocardial infarction (AMI) patients undergoing PCI [3],
nd no-reﬂow phenomenon has been observed in 11.5% of
atients [6]. Distal protection devices and thrombectomy
evices have been used to prevent these thromboembolic
omplications during PCI. Several studies have demon-
trated that a combination of these devices and PCI can
educe myocardial damage with improvement in myocar-
ial reperfusion [7—15], and result in prevention of left
entricular (LV) remodeling and better clinical outcomes
han conventional PCI [7,8,13—16]. However, the Enhanced
yocardial Efﬁcacy and Recovery by Aspiration of Liberated
ebris (EMERALD) trial failed to show the beneﬁts of dis-
al protection device during PCI for STEMI [17]. The AIMI
rial also did not demonstrate the efﬁcacy of mechanical
hrombectomy [18]. Thus, the efﬁcacy of the prevention
gainst thromboembolic complications has not been fully
valuated, and differences in efﬁcacy according to the
ocation of AMI have not been determined. In this retrospec-
ive study, we sought to evaluate the efﬁcacy of manual
hrombectomy during PCI for STEMI and clarify whether




he patient population consisted of a nonrandomized ret-
ospective cohort of patients with STEMI who had been
dmitted to the Chiba Cardiovascular Center. Of 233 con-
ecutive patients with STEMI who were treated at the Chiba
ardiovascular Center between October 2001 and January
004, 183 patients with STEMI who underwent PCI within
4 h after onset were enrolled in the study. Thrombectomy
uring PCI was performed after December 2002, because
he thrombectomy device was not available at our hos-
ital before then. Among 183 patients, we identiﬁed 88
atients (69 men, 64± 10 years) who had undergone PCI
ith manual thrombectomy between December 2002 and
anuary 2004 (Th+ group) and 95 patients (72 men, 64± 11
ears) who had been treated with PCI alone between Octo-
er 2001 and November 2002 (Th− group). The patients
ncluded in this study had: continuous chest pain for at
east 30min; ST-segment elevation of >0.1mV in 2 or more
ontiguous leads on a 12-lead electrocardiogram (ECG);
nd residual stenosis of less than 50%. Exclusion criteria
ere: the presence of bundle-branch block or pacemaker-
nduced rhythm on the admission ECG; a small-sized vessel
nsuitable for thrombectomy; an IRA with severe proxi-
al tortuosity; left main coronary artery (LMT) disease;
procedure performed after thrombolysis; or cardiogenic
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rocedure and device description
hrombectomy was performed using the Thrombuster
Kaneka Medix, Osaka, Japan). The device is a simple, rapid-
xchange, thrombus-aspirating catheter. The Thrombuster
ompatible with a 7-F guiding catheter was used and aspi-
ation was manually performed with a syringe.
After the wire was passed across the lesion, we initially
erformed manual thrombectomy with the Thrombuster,
nd then dilated the lesion with a balloon and/or stent.
n the Th− group, PCI was performed following standard
ethods without thrombectomy.On admission, all patients
eceived 81—100mg of aspirin and 100mg of ticlopidine,
nd they were treated with intravenous nitroglycerin and
icorandil. The patients were intravenously injected with
000U of heparin before the coronary angiogram; they
ubsequently received intravenous heparin continuously for
ore than 48 h. The patients were administered aspirin
81—100mg/day) and ticlopidine (200mg/day) orally for at
east 4 weeks. Aspirin was then administered continuously.
lycoprotein IIb/IIIa receptor inhibitors were not used in this
tudy.
ngiographic analysis
ntegrade coronary ﬂow was graded using standard
hrombolysis In Myocardial Infarction (TIMI) criteria [19].
yocardial blush (MB) grade at the end of the procedure
as evaluated according to the report from van’t Hof et al.
20]. No-reﬂow phenomenon was deﬁned as TIMI ﬂow grade
2 in the absence of residual stenosis or dissection at the
reatment site [5]. Distal embolization was deﬁned as a dis-
al ﬁlling defect with abrupt cutoff in one of the peripheral
oronary branches of the IRA.
Left anterior descending artery (LAD) lesions were
ivided into 2 groups according to the location of the
ccluded lesion. A proximal LAD lesion was deﬁned as the
ocation until giving the ﬁrst major septal branch, and a dis-
al LAD lesion was deﬁned as the location after the ﬁrst
ajor septal branch.Coronary angiogram and left ventricu-
ography were performed at discharge and 6 months after
he procedure. The left ventricular ejection fraction (LVEF)
as calculated using the area-length method with biplane
eft ventriculography (CAASII system; Pie Medical Imaging
.V., Maastricht, the Netherlands).
lectrocardiographic analysis
12-lead ECG was recorded on admission and 30min after
CI. The sum of ST-segment elevations was measured man-
ally 40ms after the end of the QRS complex from leads
, aVL, and V1—V6 for LAD occlusion and II, III, aVF, V5,
6, and reciprocal ST-segment depressions in V1 and V2 for
ight coronary artery (RCA) and left circumﬂex artery (LCX)
cclusions [21]. ST-segment resolution (STR) after PCI was
eﬁned as a reduction ratio of the sum of ST-segment ele-
ations between the initial and post-PCI ECG. STR ≥70% was
onsidered complete STR [22].
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Table 1 Clinical characteristics.
Th− (n = 95) Th+ (n = 88) p-Value
Gender (% male) 72 (75.8%) 69 (78.4%) NS
Age (years) 64± 11 64± 10 NS
Hypertension 60 (63.2%) 53 (60.2%) NS
Hyperlipidemia 53 (55.8%) 46 (52.3%) NS
Diabetes mellitus 30 (31.6%) 28 (31.8%) NS
Prior MI 7 (7.4%) 9 (10.2%) NS
Smoking 59 (62.1%) 55 (62.5%) NS













aElapsed time (h) 4.6± 4.2
Use of IABP 21 (22.1%)
Th, thrombectomy; MI, myocardial infarction; CK, creatine kinase
Statistical analysis
Continuous variables are expressed as the mean± SD and
were compared using Student’s t-test. Categorical variables
are expressed as the number of patients and percentages,
and were compared using a chi-square test or Fisher’s exact
test, as appropriate. A value of p < 0.05 was considered
statistically signiﬁcant. All analyses were performed using
StatView 4.5 (SAS Institute Inc., Cary, NC, USA).
Results
There were no signiﬁcant differences in patient character-
istics between the two groups (Table 1).Procedural data and angiographic analysis
Procedural and angiographic data are reported in Table 2.






Table 2 Angiographic and procedural characteristics.





Collateral ﬂow 56 (58.9%)





Distal embolization 26 (27.4%)
No-reﬂow phenomenon 22 (23.2%)
Number of balloons 1.1± 0.4
Number of stents 1.2± 0.6
Stent diameter (mm) 3.4± 0.45
Th, thrombectomy; LAD, left anterior descending coronary artery; LCX,
coronary artery disease; VD, vessel disease; TIMI, Thrombolysis In Myoc5.8± 5.1 NS
10 (11.4%) NS
P, intra-aortic balloon pumping; NS, not signiﬁcant.
tents used during the procedure was signiﬁcantly smaller in
he Th+ group. The incidences of distal embolization and no-
eﬂow phenomenonwere signiﬁcantly lower in the Th+ group
6.8% vs. 27.4%, p = 0.0003; and 5.7% vs. 23.2%, p = 0.0009,
espectively).
yocardial reperfusion
fter the procedure, MB grade 3 percentage was signiﬁcantly
igher in the Th+ group than in the Th− group (Table 2).
CG results are reported in Table 3. Compared to the Th−
roup, the percentage of complete STR was signiﬁcantly
igher in the Th+ group (43.2% vs. 20%, p = 0.002). This was
lso the case for patients with RCA lesions (59.5% vs. 30.3%,
< 0.05). In patients with LAD and LCX lesions, although the
ercentage of complete STR was higher in the Th+ group, the
ifference was not statistically signiﬁcant. In proximal LAD
esions, the percentage of complete STR was signiﬁcantly
igher in the Th+ group (37.5% vs. 9.7%, p < 0.05). However,












left circumﬂex coronary artery; RCA, right coronary artery; CAD,
ardial Infarction; MB, myocardial blush; NS, not signiﬁcant.
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Table 3 Electrocardiographic analysis: complete STR.
All patients
Th− (n = 95) Th+ (n = 88) p-Value
Complete STR 19 (20.0%) 38 (43.2%) 0.002
LAD lesions LCX lesions RCA lesions
Th− (n = 51) Th+ (n = 41) p-Value Th− (n = 11) Th+ (n = 10) p-Value Th− (n = 33) Th+ (n = 37) p-Value
Complete STR 7 (13.7%) 12 (29.3%) NS 2 (18.2%) 4 (40%) NS 10 (30.3%) 22 (59.5%) <0.05
Proximal LAD lesions Distal LAD lesions







































mComplete STR 3 (9.7%) 9 (37.5%)
Th, thrombectomy; STR, ST-segment resolution; LAD, left anteri
RCA, right coronary artery; NS, not signiﬁcant.
n patients with distal LAD lesions, there was no signiﬁcant
ifference between the 2 groups.
eft ventricular function
VEF results are shown in Fig. 1. Left ventriculography was
erformed in 129 patients (Th+, 66; Th−, 63) at discharge
nd 6 months after the procedure. The LVEF was similar
etween the two groups at discharge, but was signiﬁcantly
igher in the Th+ group 6 months after the procedure (60.1%
s. 54.8%, p = 0.004).
linical outcomes
here were no signiﬁcant differences between the two
roups in the incidences of adverse events 6 months after
he procedure (Table 4).iscussion
he present study suggests that manual thrombectomy dur-
ng PCI for STEMI prevents distal embolization and reduces
igure 1 Comparison of the left ventricular ejection fraction
LVEF) evaluated at discharge and at 6 months after the proce-
ure. LVEF was similar between the 2 groups at discharge, but
as signiﬁcantly higher in the Th+ group at 6 months after the








p05 4 (20.0%) 3 (17.6%) NS
scending coronary artery; LCX, left circumﬂex coronary artery;
o-reﬂow phenomenon, and results not only in optimal
yocardial reperfusion after PCI but also in improvement of
V function late after the procedure. With regard to differ-
nt IRAs, manual thrombectomy for STEMI is more effective
or proximal LAD and RCA lesions than for distal LAD and LCX
esions.
he efﬁcacy of manual thrombectomy during PCI
or STEMI
istal embolization and no-reﬂow phenomenon during PCI
or STEMI reduce myocardial reperfusion and can cause
arger myocardial damage and poor outcomes after PCI
2—5]. Myocardial reperfusion can be assessed using surro-
ate markers such as STR and MB grade; incomplete STR and
ower MB grade are also signs of a poor prognosis [20,22—24].
herefore, one of the goals of PCI for STEMI is achieve-
ent of complete STR and MB grade 3 with reduction of
hromboembolic complications, suggesting good myocardial
eperfusion and leading to improvement in left ventricular
unction late after the procedure [5,20,23]. In the present
tudy, the Th+ group had lower incidences of distal emboliza-
ion and no-reﬂow phenomenon than the Th− group. These
raits were associated with a higher percentage of post-
rocedural MB grade 3 in the Th+ group, and the number of
atients with complete STR was also larger in the Th+ group.
Table 4 Adverse events.
Th− (n = 95) Th+ (n = 88) p-Value
VT/Vf (in-hospital) 32 (33.7%) 24 (27.3%) NS
TLR 11 (11.6%) 16 (18.2%) NS
Death 3 (3.2%) 3 (3.4%) NS
CABG 4 (4.2%) 2 (2.3%) NS
SAT 3 (3.2%) 1 (1.1%) NS
Th, thrombectomy; VT, ventricular tachycardia; Vf, ventricular
ﬁbrillation; TLR, target lesion revascularization; CABG, coronary



















































CEfﬁcacy of thrombectomy for acute myocardial infarction
Moreover, the Th+ group had higher LVEF 6 months after the
procedure. It has been reported that thrombectomy during
PCI for STEMI prevents LV remodeling late after the pro-
cedure [7]. Hence, it seems that manual thrombectomy at
the lesion site improves myocardial reperfusion by reducing
thromoboembolic complications during PCI [7,10—15], and
it could result in better LV function recovery.
Differences in the efﬁcacy of thrombectomy
according to different IRAs
Regarding different IRAs, the percentage of complete STR
was signiﬁcantly higher in patients with proximal LAD and
RCA lesions in the Th+ group. There are several possible
reasons for these results, discussed below.
RCA lesions
Compared to the LAD, the RCA is usually a large tortuous
vessel with a slower ﬂow rate and fewer branching vessels
[25]. Because of these speciﬁc anatomical features, a larger
thrombus can form in the IRA of the RCA, leading to distal
embolization and no-reﬂow phenomenon during mechanical
revascularization for AMI [25,26]. Thus, thrombectomy may
be more effective for RCA lesions, and this contributes to a
higher percentage of complete STR after PCI.
Proximal LAD lesions
A proximal LAD lesion subtends a larger area of the
myocardium than a distal LAD lesion; accordingly the infarct
area also tends to be larger in the former [27,28]. It would be
expected that thrombectomy in a proximal LAD lesion may
save a larger area of the myocardium, and this may con-
sequently improve a larger area of myocardial reperfusion.
Moreover, for proximal LAD lesions, it has been reported that
restored epicardial ﬂow tends to be slower after thromboly-
sis [29], and MB grade decreases after PCI [27]. These results
suggest that the incidence of no-reﬂow phenomenon is apt
to be higher in proximal LAD lesions. Therefore, thrombec-
tomy that can reduce the thrombus and atherosclerotic
debris affecting the microvasculature may be more useful
in proximal LAD lesions, improving myocardial reperfusion.
Clinical outcomes
The TAPAS trial and the EXPIRE trial demonstrated the
beneﬁts of adjunctive manual thrombectomy in reducing
mortality compared with conventional PCI among patients
with STEMI [15,16]. In this study, while manual thrombec-
tomy led to a higher rate of complete STR after PCI and
LV function recovery at 6 months, mortality was similar in
both groups. Complete STR should be related to reduction
in mortality as well as LV function recovery [23]. The dis-
crepancy between our results and the previous reports may
be related to differences in the follow-up period. The TAPAS
trial and the EXPIRE trial assessed mortality at 1 year and 9
months after the procedure, respectively, and both of these
periods were longer than ours. It has been demonstrated
that myocardial reperfusion may affect long-term mortality
[2,3,5,21,30]. Moreover, the extended follow-up period may






omparison with previously reported studies
he present study demonstrated the efﬁcacy of manual
hrombectomy during PCI for STEMI. However, the EMER-
LD trial using a distal protection device failed to reduce
hromboembolic complications or to show any improvement
n STR, MB grade, or infarct size in patients with STEMI
17]. The AIMI trial also did not demonstrate the efﬁcacy
f mechanical thrombectomy [18]. The reasons for these
onﬂicting results are unknown; however, differences in
oth patient selection and thrombectomy device provide
ossible explanations. Patients enrolled in the EMERALD
rial had shorter elapsed time after onset and better TIMI
ow grade [17] than ours and other trials showing favor-
ble effects of thrombectomy [7,10—15]. In the AIMI trial,
IMI ﬂow grade might be also better [18]. In contrast, the
resent study consisted of those with STEMI within 24 h
fter onset, and the number of patients with TIMI ﬂow
rade ≥2 before PCI was smaller than the EMERALD trial
r the AIMI trial. Early reperfusion time and TIMI ﬂow grade
2 before PCI have been reported to be independent pre-
ictors of freedom from no-reﬂow phenomenon after PCI
26], whereas longer ischemic time reduces the extent of
omplete STR and enlarges the infarct size [23]. In addi-
ion, not all adjunctive thrombectomy devices are similar
n efﬁcacy during PCI for STEMI [31]. These factors may
xplain why no beneﬁts of distal protection and/or mechan-
cal thrombectomy were shown in the EMERALD trial or the
IMI trial.
tudy limitations
here were several limitations in the present study. First,
he present study was a retrospective single-center study
ith a limited number of patients, and the results should
e conﬁrmed with a large cohort trial. In particular, the
umber of patients for evaluating the efﬁcacy of man-
al thrombectomy for different IRAs was limited and these
esults should be conﬁrmed in a larger trial. Second, because
igh-risk patients, such as patients with cardiogenic shock
r LMT lesions, were excluded from this study, this may
ave inﬂuenced the angiographic results and clinical out-
omes after the procedure [30]. Third, the number of
alloons and stents used during PCI was larger in the
h− group, and this could have inﬂuenced the results
or reperfusion [32]. Fourth, we evaluated ‘‘angiographic’’
o-reﬂow phenomenon by coronary angiogram; therefore
ome cases with inadequate reperfusion could actually have
een included in the TIMI ﬂow grade 3 group [33]. Finally,
lycoprotein IIb/IIIa receptor inhibitors were not used in
his study, and the absence of glycoprotein IIb/IIIa recep-
or inhibitors could inﬂuence the rate of complete STR
34].
onclusionsanual thrombectomy for STEMI can improve myocardial
eperfusion after PCI and LV function late after the proce-
ure. With respect to different IRAs, manual thrombectomy
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